Knowledge, attitude, and practice on and willingness to pay for human papillomavirus vaccine: a cross-sectional study in Hanoi, Vietnam.

Autor: Tran BX; Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Than PTQ; Department of Health Sciences, College of Health and Human Development, California State University, Northridge CA, USA., Doan TTN; Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam., Nguyen HLT; Institute for Global Health Innovations, Duy Tan University, Da Nang, Vietnam., Thi Mai H; Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam., Nguyen THT; Institute for Global Health Innovations, Duy Tan University, Da Nang, Vietnam., Le HT; Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam., Latkin CA; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Zhang MW; Biomedical Global Institute of Healthcare Research & Technology (BIGHEART), National University of Singapore, Singapore., Ho RC; Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Jazyk: angličtina
Zdroj: Patient preference and adherence [Patient Prefer Adherence] 2018 May 30; Vol. 12, pp. 945-954. Date of Electronic Publication: 2018 May 30 (Print Publication: 2018).
DOI: 10.2147/PPA.S165357
Abstrakt: Background: Despite its effectiveness in preventing human papillomavirus (HPV) infection, the rate of uptake of the HPV vaccine is low in Vietnam. This study aimed to investigate barriers related to knowledge-attitude-practice (KAP) about the HPV vaccine and willingness to pay (WTP) for the vaccine among those using services in an urban vaccination clinic in Hanoi, Vietnam.
Materials and Methods: A cross-sectional study was conducted in a vaccination clinic of the Institute for Preventive Medicine and Public Health in Hanoi, Vietnam, from March to April 2016. KAP on the HPV vaccine was collected using a structured questionnaire. Double-bounded dichotomous-choice questions with open-ended questions were used to examine the WTP of respondents. Interval regression and stepwise logistic models were used to identify factors associated with WTP and the average amount that people would be willing to pay for the vaccine.
Results: Of 492 vaccination service users, 67.9%, 94.6%, and 12.3% of respondents were aware of the best age for HPV vaccination, its benefits, and the target group for vaccination, respectively. While the majority believed that the HPV vaccine was safe (92.8%) and effective (90.8%), and desired to be vaccinated (71.1%), only 31.8% of users were vaccinated. Most of the respondents were willing to pay for the HPV vaccine (86.6%), and willing to pay an average amount of US$49.3. Those aged 20-29 years and earning more than 22 million VND/month (very rich) were more likely to pay for the HPV vaccine than people aged <20 years and earning <7 million VND/month. Users who had attained more than a high-school education and heard about the HPV vaccine from doctors, nurses, or other health professionals tended to be willing to pay for the vaccine at a lower price than individuals with below secondary-level education and who had not heard about the vaccine from these health professionals.
Conclusion: Sexual health education and financial assistance should be imparted alongside the HPV vaccination program.
Competing Interests: Disclosure The authors report no conflicts of interest in this work.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje